Dear Attendees,
We are pleased to invite you to our 4th Symposium in Miami, Florida.
This year, LD TECHNOLOGY is proud to present several new medical applications that we have had the chance to develop throughout the year and we will also share our new project for 2012 with you.
Between 2010 and 2011 the LD TECHNOLOGY team managed to receive 3 new FDA 510K approvals for the products EIS-GS, ESO and ES-BC, opening new opportunities in the use and promotion of our biosensors.
We also completed several clinical investigations in Miami University and UNICAMP University.
With a total of 7 clinical investigations, LD TECHNOLOGY has published 4 studies in prestigious journals this year, and completed 2 new research projects.
Results of these new studies are very impressive and open new medical applications of great importance.
Therefore, LD TECHNOLOGY and its team decided to design new software and improve the management of the data recorded by the different technologies.
The company will have also pleasure in introducing its 2012 project and launching TELEMEDICINE.
Over the last 5 years, LD TECHNOLOGY products and strategies has aimed to improve the quality of care by providing primary care doctors, health care practitioners, nursing homes and hospitals with non-invasive, fast and low cost medical biosensors to understand patients’ physiological responses.
By improving screening, monitoring of treatment effectiveness and by assisting physicians in their therapeutic management plans, LD TECHNOLOGY expects to improve therapeutic control of major pandemic diseases, like diabetes, hypertension, metabolic syndrome, hepatitis and prostate cancer and therefore participate in decreasing the costs of health care systems.
We look forward to seeing you at this new symposium and to sharing the new opportunities of LD TECHNOLOGY products and services with you.
Sincerely
LD Team
Registration : This e-mail address is being protected from spambots. You need JavaScript enabled to view it
FIME EXHIBITION MIAMI BEACH
Thank you to the visitors
Jackson Memorial Hospital Miami USA.
We are pleased to invite you to our 4th Symposium in Miami, Florida.
This year, LD TECHNOLOGY is proud to present several new medical applications that we have had the chance to develop throughout the year and we will also share our new project for 2012 with you.
Between 2010 and 2011 the LD TECHNOLOGY team managed to receive 3 new FDA 510K approvals for the products EIS-GS, ESO and ES-BC, opening new opportunities in the use and promotion of our biosensors.
We also completed several clinical investigations in Miami University and UNICAMP University.
With a total of 7 clinical investigations, LD TECHNOLOGY has published 4 studies in prestigious journals this year, and completed 2 new research projects.
Results of these new studies are very impressive and open new medical applications of great importance.
Therefore, LD TECHNOLOGY and its team decided to design new software and improve the management of the data recorded by the different technologies.
The company will have also pleasure in introducing its 2012 project and launching TELEMEDICINE.
Over the last 5 years, LD TECHNOLOGY products and strategies has aimed to improve the quality of care by providing primary care doctors, health care practitioners, nursing homes and hospitals with non-invasive, fast and low cost medical biosensors to understand patients’ physiological responses.
By improving screening, monitoring of treatment effectiveness and by assisting physicians in their therapeutic management plans, LD TECHNOLOGY expects to improve therapeutic control of major pandemic diseases, like diabetes, hypertension, metabolic syndrome, hepatitis and prostate cancer and therefore participate in decreasing the costs of health care systems.
We look forward to seeing you at this new symposium and to sharing the new opportunities of LD TECHNOLOGY products and services with you.
Sincerely
LD Team
Registration : This e-mail address is being protected from spambots. You need JavaScript enabled to view it
FIME EXHIBITION MIAMI BEACH
Thank you to the visitors
Jackson Memorial Hospital Miami USA.
Estimation of Cardiac Output using the Electro Sensor Oxi (E.S Oxi) Device
John E. Lewis1, Angelica B. Melillo1, Susanna Leonard1, Nicole Quicuti1, Janet Konefal1, and Judi M. Woolger2
1Department of Psychiatry and Behavioral Sciences and 2Department of Medicine University of Miami Miller School of Medicine, Miami, FL 33136
Final Report 05.03.2011
LD Technology Received US FDA 510K for the E.S BC system
The Electro Sensor Oxi (ES Oxi) is a device used to display the SPo2 %, the digital pulse wave form (photoplethysmography) and heart rate detection. The wave form and heart rate variability analysis provides specific algorithm to estimate the cardiac output. The objective of this study was to compare the ES Oxi algorithm to a standardized assessment of cardiac output. Fifty-one subjects between 18 and 65 years of age were assessed by the ES Oxi and the BioZ Dx devices. The correlations between the ES Oxi and the BioZ Dx were very high (r=0.693 (p < 0.0001) at baseline, r=0.79 (p < 0.0001) after the first exercise stage, and r=0.86 (p < 0.0001) after the second exercise stage, respectively), suggesting that the ES Oxi algorithm has predictive capability of cardiac output. The results of the study suggest that the ES Oxi device is a very useful, safe, fast, and non-invasive way of estimating CO.
Jackson Memorial Hospital is an accredited, non-profit, tertiary care hospital and the major teaching facility for the University of Miami Leonard M. Miller School of Medicine. With more than 1,550 licensed beds, Jackson Memorial Hospital is a referral center, a magnet for medical research, and home to Ryder Trauma Center - the only adult and pediatric Level 1 trauma center in Miami-Dade County.
LD Technology Received US FDA 510K for the E.S BC system
The 510(k) K103026 is the fourth 510 (k) FDA clearance obtained by LD Technology allowing the company to continue a leading role in biosensors technology .
December 13, 2010
December 13, 2010
LD Technology Received US FDA 510K for the EIS system
"We are extremely pleased to have received the FDA's 510k (number K102166) clearance for the EIS system,
which represents an important step forward in the improvement of our Medical Devices," said Albert Maarek Chief Executive Officer.
The EIS-GS Galvanic Skin Response Measurement Device is the third FDA 510k cleared Medical Devices for LD Technology (a ISO 13485 manufacturer) .
The other products in the US include the E.S. Teck PEMS and E. S. Oxi.
which represents an important step forward in the improvement of our Medical Devices," said Albert Maarek Chief Executive Officer.
The EIS-GS Galvanic Skin Response Measurement Device is the third FDA 510k cleared Medical Devices for LD Technology (a ISO 13485 manufacturer) .
The other products in the US include the E.S. Teck PEMS and E. S. Oxi.
E.S.O (Electro Sensor Oxi) US FDA 510k Clearance
September 10, 2010
LD Technology commitment to excellence in medical bio sensor research has been confirmed by the FDA 510k clearance of the :
Electro Sensor Oxi (E.S.O)
Regulatory number : 21CFR 870 2700
510 k number 102442
Product Code : DQA, MWI
September 10, 2010
LD Technology commitment to excellence in medical bio sensor research has been confirmed by the FDA 510k clearance of the :
Electro Sensor Oxi (E.S.O)
Regulatory number : 21CFR 870 2700
510 k number 102442
Product Code : DQA, MWI
LD Technology and Softmed technology will be present to Medica 2010 Florida Pavilion.
LD SYMPOSIUM 2010 December 10-11.
Miami Beach Resort Hotel
4833 Collins Ave
Miami Beach, Fl 33141
Reservation Can Be made At (305) 532-3600 or Toll Free At 1-888-552-2852
The Cost Is $139.00 Per Night
Seminar Registration
Tel: +1 305 594 2145/+1 305 379 9900
Email:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Cost: FREE with EIS/ES Teck ownership and/or personal invitation from Dr. Albert Maarek.
With the Participation of Dr.
John Lewis Jackson Memorial Hospital Join us for an incredible 2 days of learning and sharing.
Warmly
Albert Maarek MD
Richard Clement MD